New heart device registry launches in belgium to monitor Real-World safety
NCT ID NCT07156851
First seen Oct 01, 2025 · Last updated Apr 28, 2026 · Updated 22 times
Summary
This study will follow 100 adults in Belgium who have received or will receive an extravascular implantable cardioverter-defibrillator (EV-ICD) as part of their normal care. Researchers will collect data from medical records to track how well the device detects and treats dangerous heart rhythms, any complications, and the patient's quality of life. No extra visits or tests are required beyond standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.